1.4K
Downloads
28
Episodes
Welcome to BioChat, a podcast by ABclonal Technology. With this show, we aim to familiarize you with not only ABclonal’s contributions to efforts in scientific discovery, but also to highlight the direction of ongoing bioscience research and to help scientists determine how best to leverage their skills to improve global human health and quality of life.
Episodes
Tuesday Jan 23, 2024
Tuesday Jan 23, 2024
The Chief Scientific Officer at Yurogen, Hao Cheng, PhD, joins BioChat to discuss the necessity of antibody engineering to produce safer and more effective research tools and therapeutics. Dr. Cheng gives insight into the many considerations and processes involved in taking an antibody from its raw form to an optimized reagent with altered binding dynamics and/or improved deliverability.
We also invite you to listen to Dr. Wu's discussion of the SMab platform here.
Yurogen is a subsidiary of ABclonal Technology, you can visit our website at Yurogen.com. To view the presentation of our antibody engineering platform, please fill out our form here.
Please feel free to visit us at www.abclonal.com, read our blog posts here, including an introduction to what we're hoping to accomplish with BioChat, and check out our Doctor Beaker page for fun activities! You can also find all the ways to subscribe to our podcast via our BioChat page, which includes Apple Podcasts and Spotify.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.